Commercializing biomedical innovation is nuanced and complex. The process for delivering life-changing care to the public requires a continuous cycle of innovation. Weill Cornell Medicine Enterprise Innovation provides a bridge between academic researchers and industry and investment stakeholders, brokering engagements and alliances, engaging with and educating faculty and trainees about biomedical commercialization and business development and developing entrepreneurial programming, education, mentoring and other resources.
Our team of top-tier business development experts works collaboratively with a network of partners to commercialize biomedical technology in verticals including therapeutics, devices, diagnostics and precision medicine, tangible properties, digital health and data assets. Enterprise Innovation’s cohesive and dynamic team aims to lead the market by developing and delivering next generation innovation in human health. Search our technologies database to discover new opportunities for partnership.
We also encourage prospective partners to explore additional technologies available from Cornell University covering a broad range of research innovations at the forefront of the latest challenges including sustainability, HiTech, agriculture, and life and veterinary sciences.